Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHARMACOLOGY > Asthma > Flashcards

Asthma Flashcards

1
Q

State the sympathetic and parasympathetic innervation of the resp system and effects thereof

A

B2 adrenoceptors (cause relaxation of bronchial smooth muscle, leading to dilation)

M3 receptors: cause bronchial muscle contraction&raquo_space; bronchoconstriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Common symptoms of pulmonary disease

A

Wheezing
SOB
Cough (wet or dry), or hemoptysis
chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes respiratiory conditions? (2)

A

Infection
Malignancy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is asthma? Explain. (2)

A

Inflammatory condition with
recurrent reversible airway
obstruction in response to
irritant stimuli.
* Intermittent attacks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Common sysmptoms of asthma(4)

A

Symptoms include wheezing,
shortness of breath, difficulty
breathing out, sometimes cough
(worse at night)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Who mostly become affected by asthma?

A

Common in children with atopy
(allergic rhinitis and atopic
dermatitis) = allergic asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Asthma is characterised by: (3)

A

Inflammation of the
airways
* Bronchial
hyperreactivity
* Reversible airway
obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens in the immediate phase of asthma?

A

Inciting agent: alletgen or non-specific stimulant» activation of mast cells and mononuclear cells&raquo_space; release of H, cystLTs, and PGD2, AND release of chemokines and chemotaxins&raquo_space; Bronchospasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment of immediate phase asthma?

A

M3 antagonists
B2 adrenoceptor agonists
cysLT antagonists
Theophylline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Explain the late phase of asthma

A

The chmokines released during the immediated phase will lead to the production of chemokine releasing Th2 cells, mononuclear cells and inflammatory cells esp eosinophils&raquo_space; release of cysLT, NO, adenosine, neuropeptides, AND Eosinophil Major Basic Protein (EMBP) and Eosinophil Cationic Protein (ECP).

EMBP and ECP cause epithelial cell damage, which causes airway hyperactivity. Together with other secretions, also causes Airway inflammation.

All this ultimately leads to bronchospasm, wheezing, and coughing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Treatment of the late phase

A

Glucocorticoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What does PEFR do? Why is it important?

A

Volume of air forcefully
expelled from the lungs in
one quick exhalation
* Reliable indicator of
ventilation adequacy as
well as airflow obstruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List 3 factors leading to differences in PEFR

A

Age, Height, Sex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does one calculate predicted peak flow rate? (4)

A

CALCULATING % PREDICTED PEAK
FLOW RATE
* Take the best of 3 of the patient’s observed peak flow rate
* Find the patient’s sex, age and height predicted value from nomogram or table:
* Divide patient’s observed peak flow rate over their predicted peak flow.
rate
* Multiply by 100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

List 5 drug classes used in the treatment of asthma

A

B2 agonists
M3 antagonists
Glucocorticoids
Xanthines
Leukotrine receptor antagonist

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of B2 adrenoceptor agonists. Classify into short acting and long acting

A

Salbutamol and fenoterol, terbutaline - SABA,
Salmeterol and Formoterol - LABA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Examples of M3 antagonists and ROA

A

iptratropium bromide, tiotropium (Inhaled)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Examples of Glucocorticoids and ROA

A

Beclomethasome, budesonide, fluticasone (INHALED)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Examples of Xanthines and ROA

A

Aminophylline, theophylline (IV, Oral)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Examples of Leukotriene receptor antagonists and ROA

A

Montelukast, ORAL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What is the MOA of B2 agonists?

A

β₂ activation causes relaxation of the bronchial smooth muscle
* May increase mucous clearance by an action on cilia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

SABA clinical use/indication, ROA,
Onset of action (time),
Max effect (time),
overall duration of action (time)

A

Clinical use/indication: acute bronchospasm
* Inhaled (Onset of Action: 5-15 min)
* Max effect within 30 min
* Duration of Action: 4-6 hrs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Salbutamol dosage

A

1 or 2 puffs, prn as required

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

________________ can develop to bronchodilator effects
with continuous/inappropriate use.

A

Tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Indication of LABA

A

COPD, Uncontrolled persistent asthma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

LABA must always be used with ________________ in asthma

A

steroid

27
Q

Give the following info for LABA
ROA
Duration of action
Administer how many times?

A

Inhaled (onset of action – longer than for SABAs)
* Duration of action: 8-12 hours
* Administer twice daily consistently

28
Q

You cannot use salmeterol in which circumstance?

A

– do not use
salmeterol in an acute attack

29
Q

Give Adverse effects of B2 agonists (9)

A

Skeletal muscle tremor, headache dizziness, tachycardia, palpitations – dose-related
* Nervousness (β₂ stimulation increase the release of catecholamine’s
at nerve terminals)
* Dry mouth, taste alteration and discolouration of teeth

30
Q

T/F: B2 Agonists adverse effects are less pronounced with oral administration

A

F

31
Q

B2 agonist cautions

A

Cardiac arrhythmias, IHD, CHF,
uncontrolled HT,
hyperthyroidism
Pregnancy

32
Q

Why is B2 agonist cautioned in pregnancy?

A

may delay labour,
asthma need to be well
controlled, inhaled preparations
preferred

33
Q

Which drug class may cause interactions if/when used with B2 agonists?

A

(non-selective) B-Blockers

34
Q

Importance of glucocorticoids:

A

Anti-inflammatory – mainstay in preventing acute attacks.
* NOT bronchodilators
* Prevent progression of chronic asthma

35
Q

MOA of glucocorticoids in asthma

A

Restrain clonal proliferation of Th cells by reducing the transcription of the gene for IL-2 and decrease formation of cytokines, in particular the Th2 cytokines that recruit and activate eosinophils and are responsible for promoting the production of IgE and the expression of IgE receptors.

36
Q

MOA of glucocorticoids in asthma cont… (5)

A

Inhibit the allergen-induced influx of eosinophils into the lung.
*Up-regulate β 2 adrenoceptors,
*Decrease microvascular permeability
*Indirectly reduce mediator release from eosinophils by inhibiting the
production of cytokines (e.g. IL-5 and granulocyte–macrophage
colony-stimulating factor) that activate eosinophils.
*Reduce synthesis of IL-3 (the cytokine that regulates mast cell
production) i.e. may explain why long-term steroid treatment
eventually reduces the number of mast cells in the respiratory
mucosa, and hence suppresses the early-phase response to allergens
and exercise

37
Q

which glucocorticoids are inhaled and what is their effect?

A

Inhaled corticosteroids (ICS) (beclomethasone, budesonide,
fluticasone): chronic treatment of persistent asthma

38
Q

which glucocorticoids are taken oral and what is their effect?

A

Oral treatment (prednisone): for exacerbation (attack) or when
asthma is uncontrolled.

39
Q

which glucocorticoids are taken IV and what is their effect?

A

IV treatment (hydrocortisone): severe bronchospasm, not able to
take oral.

40
Q

Frequency of dose for glucocorticoids

A

2x a day

41
Q

How much of glucocorticoid is distributed to the lung?

A

10-15%

42
Q

After how long can u see improvement from glucocorticoid use?

A

1-4 WEEKS
adherence is
important for optimal effectiveness (educate on prophylactic use,
continue treatment even when symptom free)

43
Q

What education can u give a pt regarding glucocorticoid use?

A

continue Tx even when symptom free (prophylaxis)
Rinse mouth after use to prevent oral candida

44
Q

adverse effects of inhaled glucocorticoids (3)

A

Oral candida, hoarseness, sore throat

45
Q

MOA of M3 antagonist

A

block contraction of airway smooth muscle
mediated via M₃-receptors and inhibit augmentation of mucous
secretion that occurs in response to vagal stimulation. Increase
mucociliary clearance of bronchial secretions.

Response vary among individuals: only inhibit portion of bronchoconstrictive response mediated via parasympathetic pathways, more effective in COPD and the elderly

46
Q

Onset of action and duration of action of Ipratropium

A

Onset of action: 30 minutes
* Duration of action: 4 hours

47
Q

Cautions and adverse effects of ipratropium

A
  • Cautions: prostatic hypertrophy & narrow angle glaucoma
  • Adverse effects: dry mouth, bitter taste
48
Q

MOA of Xanthines

A

unclear. Relax smooth muscle via inhibition of
phosphodiesterase isoenzymes. Antagonise adenosine receptors

General CNS and resp stimulation

49
Q

Pharmacokinetics of Xanthines: Therapeutic index and absorption

A

Pharmacokinetics: narrow therapeutic index
* Oral absorption good (sustained release preferred, do not change
formulation is patient has been stabilised on it)

50
Q

Pharmacokinetics of Xanthines: Half life and metabolism

A

Half-life variable
* prolonged in infants and older patients, heart failure, hepatic disease,
concurrent infections,
* shortened by smoking and drug-interactions
* Metabolised in the liver
* Only use when other bronchodilators have failed

51
Q

Common side effects of theophylline: GI effects

A

GI effects and CNS stimulation.
* GI irritation may be minimised by taking with food to prevent N/V, epigastric
pain and intestinal bleeding.

52
Q

Common Adverse effects of theophylline: CNS effects (6)

A
  • CNS effects: headache, irritability, nervousness, tremor, insomnia,
    convulsions
53
Q

UNCOMMON ADVERSE EFFECTS OF Theophylline

A

Uncommon: tachycardia, palpitations, hypotension, arrhythmias,
hyperglycaemia, depression

54
Q

Cautions of theophylline (8)

A

IHD, Hypertension, hyperthyroidism, epilepsy, hx of PUD, liver disease, CCF,
older patients

55
Q

Theophylline drug interactions

A

Hepatic enzyme inhibitors: cimetidine, erythromycin, ciprofloxacin,
ritonavir, etc.
* Hepatic enzyme inducers: smoking, alcohol, barbiturates rifampicin,
phenytoin, carbamazepine
* Sympathomimetic agents: potentiate cardiac effects

56
Q

Montelukast indication

A

prophylaxis and chronic treatment of atopic asthma (also
treat allergic rhinitis), inhibit exercise-induced asthma

57
Q

MOA of montelukast

A

exhibit bronchodilator and anti-inflammatory activity by
blocking effects of cysteinyl leukotrienes in the airways

58
Q

ROA of montelukast

A

Administered orally
* Not indicated for acute attack (controller, take regularly)

59
Q

Adverse effects of Montelukast

A

Uncommon in general
* Hypersensitivity
* Eosinophilia (rarely)
* Neuropsychiatric events: agitation, aggression, anxiousness, hallucinations,
depression, insomnia, irritability, suicidal thinking and behaviour – Warn
patient

60
Q

How to treat mild and moderate acute asthma attack

A

Salbutamol, inhalation using a metered-dose inhaler (MDI), 4–8 puffs, using a spacer.
* Inhale one puff at a time. Allow for 4 breaths through the spacer between puffs.
* If no relief, repeat every 20–30 minutes in the first hour.
* Thereafter, repeat every 2–4 hours if needed.
* Note: Administering salbutamol via a spacer is as effective as, and cheaper than, using a nebuliser.
* OR
* Salbutamol 0.5%, solution, nebulised, with oxygen.
* 1 mL (5 mg) salbutamol 0.5% solution, in 4 mL of sodium chloride 0.9%.
* If no relief, repeat every 20–30 minutes in the first hour.
* Thereafter, repeat every 2–4 hours if needed.
* AND
* Corticosteroids (intermediate-acting) e.g.: Prednisone, oral, 40 mg immediately
* Follow with prednisone, oral, 40 mg daily for 7 days.

61
Q

Tx of severe acute asthma

A

Give oxygen with care (preferably by 24% or 28% facemask, if available). Observe patients
closely, as a small number of patients’ condition may deteriorate.
* AND
* Salbutamol 0.5%, solution, nebulised, with oxygen.
* 1 mL (5 mg) salbutamol 0.5% solution, in 4 mL of sodium chloride 0.9%.
* If no relief, repeat every 20–30 minutes until PEF > 60% of predicted.
* Once PEF > 60% of predicted, repeat every 2–4 hours if needed.

Corticosteroids (intermediate-acting) e.g.:  Prednisone, oral, 40 mg immediately.
* Follow with prednisone, oral, 40 mg daily for 7 days.

ADD (If poor response after first salbutamol nebulisation/inhalation):
* Ipratropium bromide solution, nebulised,
2 mL (0.5 mg) added to salbutamol solution every 20–30 minutes for 3 doses depending on clinical response.
OR using MDI, 80–160 mcg (2–4 puffs), using a spacer every 20–30 minutes as needed for up to 3 hours.

62
Q

Management of chronic persistent asthma (patient eductaion)

A

Non-pharmacological advice and patient education:
* No smoking by an asthmatic or in the living area of an asthmatic.
* Avoid contact with household pets.
* Avoid exposure to known allergens and stimulants or irritants.
* Education on early recognition and management of acute attacks.
* Patient and caregiver education:
* emphasise the diagnosis and explain the nature and natural course of the condition;
* teach and monitor inhaler technique; and
* reassure parents and patients of the safety and efficacy of continuous regular
controller therapy

63
Q

Medical management of severe persistent asthma

A

Medicine treatment is based on the severity of the asthma and
consists of therapy to:
(1) prevent the inflammation leading to bronchospasm (controller)
ICS: beclomethasone – use twice daily
(2) relieve bronchospasm (reliever)
SABA: salbutamol – use as needed

64
Q

Mx of exercise induced asthma

A

Administer: SABA: salbutamol 30 minutes before exercise

PHARMACOLOGY (30 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions